CAN A CURE BE ACHIEVED WITH TAXANE-BASED CHEMOTHERAPY IN PATIENTS WITH PRIMARY MEDIASTINAL NON-SEMINOMATOUS GERM CELL TUMORS (NGCT) AND PROGRESSION OR RELAPSE DESPITE FIRST-LINE CHEMOTHERAPY?

被引：0
|
作者：
Miskovska, V. [1 ]
Levy, A. [1 ]
Sauvin, L. Albiges [1 ]
Massard, C. [1 ]
Gross-Goupil, M. [1 ]
Bossi, A. [1 ]
Fizazi, K. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 205
页数：2
相关论文
共 50 条
  • [1] Can a Cure Be Achieved with Taxane-Based Chemotherapy plus Surgery in Patients with Primary Mediastinal Non-Seminomatous Germ Cell Tumors and Progression or Relapse Despite First-Line Chemotherapy?
    Miskovska, Vera
    Levy, Antonin
    Massard, Christophe C.
    Gross-Goupil, Marine
    Bossi, Alberto
    Fizazi, Karim
    ONKOLOGIE, 2010, 33 (03): : 119 - 120
  • [2] First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs)
    Pliarchopoulou, K.
    Pectasides, D.
    CANCER TREATMENT REVIEWS, 2009, 35 (07) : 563 - 569
  • [3] First-line high-dose chemotherapy for 'poor risk' metastatic non-seminomatous testicular germ cell tumors
    Bokemeyer, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Rüther, U
    Hartmann, JT
    Holstein, K
    Derigs, HG
    de Wit, R
    Casper, J
    Schöffski, P
    Kührer, I
    Illiger, HJ
    Kempf, B
    Reichle, A
    Föller, A
    Hossfeld, DK
    Fischer, JT
    Berdel, W
    Gerhartz, H
    Kirchner, H
    Pflüger, K
    Ostermann, H
    Kanz, L
    Schmoll, HJ
    ONKOLOGIE, 1998, 21 : 23 - 25
  • [4] Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience
    De Giorgi, U
    Demirer, T
    Wandt, H
    Taverna, C
    Siegert, W
    Bornhauser, M
    Kozak, T
    Papiani, G
    Ballardini, M
    Rosti, G
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 146 - 151
  • [5] Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy
    Hidalgo, M
    PazAres, L
    Rivera, F
    Lianes, P
    Huidobro, G
    Ruiz, A
    LopezBrea, M
    SanzOrtiz, J
    Lopez, JL
    CortesFunes, H
    Tabernero, JM
    ANNALS OF ONCOLOGY, 1997, 8 (06) : 555 - 559
  • [6] Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor
    Oechsle, Karin
    Lorch, Anja
    Honecker, Friedemann
    Kollmannsberger, Christian
    Hartmann, Joerg T.
    Boehlke, Ina
    Beyer, Joerg
    Bokemeyer, Carsten
    ONCOLOGY, 2010, 78 (01) : 47 - 53
  • [7] FLT-PET for monitoring chemotherapy in patients with metastatic non-seminomatous testicular germ cell tumors
    Been, LB
    Cobben, DC
    Hoekstra, HJ
    Jager, PL
    Gietema, JA
    Elsinga, PH
    Suurmeijer, AJ
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 80 - 80
  • [8] Surgical outcomes in patients with primary mediastinal non-seminomatous germ cell tumours and elevated post-chemotherapy serum tumour markers
    De Latour, Bertrand
    Fadel, Elie
    Mercier, Olaf
    Mussot, Sacha
    Fabre, Dominique
    Fizazi, Karim
    Dartevelle, Philippe
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 42 (01) : 66 - 71
  • [9] Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy
    Oechsle, K.
    Kollmannsberger, C.
    Honecker, F.
    Boehlke, I.
    Bokemeyer, C.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1663 - 1669
  • [10] Management of the post-chemotherapy residual mass in patients with advanced stage non-seminomatous germ cell tumors (NSGCT)
    Kuczyk, M
    Machtens, S
    Stief, C
    Jonas, U
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (06) : 852 - 855
12345